Dopamine Hydrochloride, USP is indicated for the correction of hemodynamic imbalances present in the shock syndrome due to myocardial infarction, trauma, endotoxic septicemia, open-heart surgery, renal failure, and chronic cardiac decompensation as in congestive failure.
From the U.S. FDA-approved label for Dopamine. Full label: DailyMed.
Dopamine Hydrochloride, USP is indicated for the correction of hemodynamic imbalances present in the shock syndrome due to myocardial infarction, trauma, endotoxic septicemia, open-heart surgery, renal failure, and chronic cardiac decompensation as in congestive failure. Patients most likely to respond adequately to Dopamine Hydrochloride, USP are those in whom physiological parameters, such as urine flow, myocardial function, and blood pressure, have not undergone profound deterioration. Multiclinic trials indicate that the shorter the time interval between onset of signs and symptoms and initiation of therapy with blood volume correction and Dopamine Hydrochloride, USP, the better the prognosis. Where appropriate, blood volume restoration with a suitable plasma expander or whole blood should be accomplished prior to administration of Dopamine Hydrochloride, USP. Poor Perfusion of Vital Organs – Urine flow appears to be one of the better diagnostic signs by which adequacy of vital organ perfusion can be monitored. Nevertheless, the physician should also observe the patient for signs of reversal of confusion or reversal of comatose condition.
From the U.S. FDA-approved label for Dopamine. Full label: DailyMed.
WARNING: This is a potent drug; it must be diluted before administration to the patient. Dopamine hydrochloride injection is administered (only after dilution) by intravenous infusion. Suggested Dilution – For the 40 mg/mL preparation, transfer by aseptic technique the contents containing either 5 mL, 200 mg or 10 mL, 400 mg of dopamine hydrochloride to either a 250 mL or 500 mL bottle of one of the sterile I.V.
Directions from the U.S. FDA-approved label — your doctor or pharmacist may advise differently.
Dopamine HCl should not be used in patients with pheochromocytoma. Dopamine HCl should not be administered to patients with uncorrected tachyarrhythmias or ventricular fibrillation.
Excerpt from the U.S. FDA-approved label. Talk to a pharmacist or doctor before use.
Contains sodium metabisulfite, a sulfite that may cause allergic-type reactions including anaphylactic symptoms and life-threatening or less severe asthmatic episodes in certain susceptible people. The overall prevalence of sulfite sensitivity in the general population is unknown and probably low. Sulfite sensitivity is seen more frequently in asthmatic than in nonasthmatic people. Do NOT add dopamine HCl to any alkaline diluent solution since the drug is inactivated in alkaline solution.
Warnings and precautions excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor before use.
The following adverse reactions have been observed, but there are not enough data to support an estimate of their frequency.
Excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor about side effects.
20 products from 20 makers in the NepalDoc medicine catalog use this generic:
| Brand | Composition | Maker | Pack |
|---|---|---|---|
| Cardidop Injection | Dopamine (200mg) | Flagship Biotech International | ampoule of 5 ml Injection |
| Domin Injection | Dopamine (40mg/ml) | Neon Laboratories Ltd | vial of 5 ml Injection |
| Dopacef 200mg Injection | Dopamine (200mg) | Chandra Bhagat Pharma Pvt Ltd | vial of 5 ml Injection |
| Dopacef 40mg Injection | Dopamine (40mg) | Vhb Life Sciences Inc | vial of 5 ml Injection |
| Dopacin 40mg Injection | Dopamine (40mg) | Troikaa Pharmaceuticals Ltd | vial of 5 ml Injection |
| Dopaclor 200mg Injection | Dopamine (200mg) | Suncure Lifescience Pvt Ltd | vial of 5 ml Injection |
| Dopaglan 200mg Injection | Dopamine (200mg) | Gland Pharma Limited | vial of 5 ml Injection |
| Dopagrin Injection | Dopamine (200mg) | Palco Healthcare | ampoule of 5 ml Injection |
| Dopakinde Injection | Dopamine (40mg/ml) | Nexokinde Healthcare Pvt Ltd | ampoule of 5 ml Injection |
| Dopamed 200mg Injection | Dopamine (200mg) | MHS Pharmaceuticals Pvt Ltd | vial of 5 ml Injection |
| Dopamine 200mg Injection | Dopamine (200mg) | TTK Healthcare Ltd | vial of 5 ml Injection |
| Dopan Injection | Dopamine (40mg/ml) | Celon Laboratories Ltd | ampoule of 5 ml Injection |
| Dopanis 40mg Injection | Dopamine (40mg/ml) | Neiss Labs Pvt Ltd | vial of 5 ml Injection |
| Dopar 200mg Injection | Dopamine (200mg) | Samarth Life Sciences Pvt Ltd | vial of 5 ml Injection |
| Dopasol 40mg Injection | Dopamine (40mg/5ml) | Shree Ganesh Pharmaceuticals | vial of 5 ml Injection |
| Dopmin 200mg Injection | Dopamine (200mg) | Xion Pharmaceuticals Pvt Ltd | vial of 5 ml Injection |
| Dopress 200mg Injection | Dopamine (200mg) | United Biotech Pvt Ltd | vial of 5 ml Injection |
| Obamaine 200mg Injection | Dopamine (200mg) | Ciron Drugs & Pharmaceuticals Pvt Ltd | vial of 5 ml Injection |
| Usedopa 200mg Injection | Dopamine (200mg) | Uniword Pharma | vial of 1 Injection |
| Vardine Injection | Dopamine (40mg/ml) | Varenyam Healthcare Pvt Ltd | ampoule of 5 ml Injection |
Brand list from the NepalDoc medicine catalog. Availability varies by pharmacy — call ahead to confirm stock.
Store at 20 to 25°C (68 to 77°F).
Storage information from the U.S. FDA-approved label.
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. NLEM listing does not guarantee that a medicine is in stock at any pharmacy.
